Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinoma.
Koschny, Ronald
Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinoma. [electronic resource] - Oncology 2013 - 6-13 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1423-0232
10.1159/000342425 doi
Aged
Aged, 80 and over
Benzenesulfonates--therapeutic use
Carcinoma, Hepatocellular--complications
Diarrhea--chemically induced
Female
Follow-Up Studies
Humans
Liver Cirrhosis--complications
Liver Neoplasms--complications
Male
Middle Aged
Nausea--chemically induced
Niacinamide--analogs & derivatives
Phenylurea Compounds
Prospective Studies
Pyridines--therapeutic use
Skin Diseases--chemically induced
Sorafenib
Survival Rate
Treatment Outcome
Vomiting--chemically induced
Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinoma. [electronic resource] - Oncology 2013 - 6-13 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1423-0232
10.1159/000342425 doi
Aged
Aged, 80 and over
Benzenesulfonates--therapeutic use
Carcinoma, Hepatocellular--complications
Diarrhea--chemically induced
Female
Follow-Up Studies
Humans
Liver Cirrhosis--complications
Liver Neoplasms--complications
Male
Middle Aged
Nausea--chemically induced
Niacinamide--analogs & derivatives
Phenylurea Compounds
Prospective Studies
Pyridines--therapeutic use
Skin Diseases--chemically induced
Sorafenib
Survival Rate
Treatment Outcome
Vomiting--chemically induced